New contraceptive shortages reported

Seven contraceptive pills are currently unavailable to prescribe, according to the MIMS drug shortages tracker.

Several oral contraceptives are currently out of stock, some of which have no exact equivalents. | GETTY IMAGES
Several oral contraceptives are currently out of stock, some of which have no exact equivalents. | GETTY IMAGES

New shortages have been reported for Norgeston (levonorgestrel) and Qlaira (estradiol valerate/dienogest), which are expected to be out of stock until the end of May and October 2021, respectively. 

Several other contraceptive products are already listed on the MIMS drug shortages tracker:

  • Akizza (ethinylestradiol/gestodene) - resupply date unknown
  • Brevinor (ethinylestradiol/norethisterone) - expected back in stock this week
  • Femodette (ethinylestradiol/gestodene) - due back in stock early May
  • Norinyl-1 (mestranol/norethisterone) - resupply date unknown
  • Yiznell (ethinylestradiol/drospirenone) - due back in stock this month.

Another ethinylestradiol/drospirenone product, Yasmin, is anticipated to be out of stock from early May until early July 2021.

In addition, the hormonal preparation Dianette (co-cyprindiol), used in the treatment of female acne and hirsutism, is currently out of stock until May.

The MIMS contraceptives table can help prescribers find suitable alternatives to products that are unavailable, although there are no exact equivalents available for Brevinor, Norinyl-1, Norgeston or Qlaira. The DHSC says unlicensed imports have been sourced for all of these products apart from Qlaira.

Want news like this straight to your inbox?
Sign up for our bulletins

Chloe Harman recommends

Table: Contraceptives

Read more

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in